Allergan Aesthetics reported results from two small single-center studies assessing topical skincare regimens, alone and paired with dermabrasion, in people undergoing medical weight loss including GLP-1 receptor agonist therapy. Investigators recorded statistically significant improvements in selected skin quality measures across the face, neck, upper inner arms and thighs, with some changes appearing by week two. The trials enrolled nine and eleven completers respectively, and the company states that larger studies are required.
Key Points
- Topical regimens improved investigator-rated skin quality during medical weight loss
- Two single-center studies included only nine and eleven completers
- Participants perceived facial skin as roughly a decade younger
Longevity Analysis
Rapid adipose loss alters the mechanical and structural environment of skin, and the dermis — a collagen-dependent tissue with slow turnover — is often the visible marker of how well regenerative capacity keeps pace with metabolic change. Supportive topical and procedural interventions belong to the optimization layer rather than the foundation: their value depends on adequate protein intake, resistance training to preserve lean mass, and hydration status during pharmacologic weight loss. Sample sizes of nine and eleven, without control arms, place these findings at the hypothesis-generating stage; the durability question — whether dermal remodeling is genuinely supported or only perceptually improved — remains open.
Original published by LT Wire.